Back
Foghorn Therapeutics, Inc. 10K Form
Sell
35
FHTX
Foghorn Therapeutics, Inc.
Last Price:
$4.37
Seasonality Move:
-23.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FHTX News And Ratings
See the #1 stock for the next 7 days that we like better than FHTX
FHTX Financial Statistics
Sales & Book Value
| Annual Sales: | $22.6M |
|---|---|
| Cash Flow: | $-18.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.59 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.18670 |
|---|---|
| Net Income (TTM): | $-72.1M |
| Gross Margin: | $19.5M |
| Return on Equity: | 0% |
| Return on Assets: | -24.76% |
Foghorn Therapeutics, Inc. Earnings Forecast
Key Foghorn Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for FHTX is 86.20%.
-
The Selling, General & Administrative Expenses for FHTX have been equal to 125.47% of Gross Profit Margin.
-
The Research & Development expenses have been 404.42% of Revenue.
-
The Net Earning history of FHTX is -383.24% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 4 years.
Foghorn Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FHTX |
| Website: | foghorntx.com |
Debt
| Debt-to-Equity Ratio: | -0.25 |
|---|---|
| Current Ratio: | 2.16 |
| Quick Ratio: | 2.13 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
FHTX Technical Analysis vs Fundamental Analysis
Sell
35
Foghorn Therapeutics, Inc. (FHTX)
is a Sell
Is Foghorn Therapeutics, Inc. a Buy or a Sell?
-
Foghorn Therapeutics, Inc. stock is rated a SellThe current Foghorn Therapeutics, Inc. [FHTX] share price is $4.58. The Score for FHTX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.